FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to experimental medicine and pharmacology, namely a method for preparing lithium salt of comenic acid (lithium comenate) by mixing a comenic acid solution heated up to temperature max. 80±2°C, with lithium carbonate or hydroxide solution in the stoichiometrically-defined amounts, and colouring the solution in yellow and reducing pH of the solution to 4.6 or 10.0 respectively, and recovering luthium salt of comenic acid from the solution by water distillation under vacuum. For this purpose, lithium salt of comenic acid is suggested to be used in the amount of 2 mg per 1 kg of body weight once daily for 3 days.
EFFECT: invention refers to the agents for preventing and treating neurodegenerative diseases caused by an brain oxidative damage.
2 cl, 2 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT POTASSIUM COMENATE | 2012 |
|
RU2514632C1 |
| ANTIOXIDANT, STRESS AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT SODIUM COMENATE | 2012 |
|
RU2506078C1 |
| PHARMACOLOGICAL NEUROPROTECTIVE DRUG | 2014 |
|
RU2561045C1 |
| NEUROPROTECTIVE PHARMACEUTICAL AGENT | 2013 |
|
RU2528914C1 |
| NEUROPROTECTIVE AGENT | 2016 |
|
RU2614697C1 |
| METHOD OF PREVENTING AND CORRECTION OF DISTURBANCES OF MAIN FUNCTIONS OF CENTRAL NERVOUS SYSTEM IN CASE OF LEAD INTOXICATION IN PRENATAL AND EARLY POSTPARTUM PERIOD | 2009 |
|
RU2410107C1 |
| METHOD FOR PREVENTING AND TREATING NEURODEGENERATIVE PATHOLOGY AND VASCULAR DEMENTIA | 2014 |
|
RU2587617C1 |
| MEANS WITH ANTISTRESS, ANXIOLYTIC AND ANTIDEPRESSANT ACTIVITY AND COMPOSITION BASED THEREON | 2015 |
|
RU2617512C1 |
| METHOD FOR PREVENTING AND CORRECTING METABOLIC AND FUNCTIONAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM UNDER STRESS CONDITIONS | 2019 |
|
RU2717107C1 |
| USE OF L-CARNOSINE FOR PRODUCING NANOPREPARATION POSSESSING ANTIHYPOXIC AND ANTIOXIDANT ACTIVITY | 2012 |
|
RU2482867C1 |
